In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical, presented an integrated, comprehensive analysis using the mint Lesion™ platform for a seamless evaluation of COVID-19 patients and trials.
Together they highlighted the need for expert image analysis and the urgent need for organized data collection, encompassing the multi-dimensional data of imaging, laboratory, clinical, and demographics for COVID-19.
While imaging should not be used as a screening tool for unselected populations, it supports a comprehensive approach which can be applied in both clinical care and clinical trials. The mint Lesion™ platform integrates this multi-dimensional data creating a digital signature for the patient while enabling data quality, integrity, and traceability acquired in a high-trust environment.
-
65 minute(s)
Radiologic Analysis of COVID-19 Infection
Related Resources
Related Resources
Creating evidence to tackle COVID-19
Our COVID-19 reading template is in use for two weeks, and its usage is multiplying. We are grateful for the close cooperation and feedback from…
Mint Medical provides a reading template for the standardized assessment and documentation of COVID-19 disease (coronavirus) based on CT imaging
In the first week of March, we will make the relevant software functions available for all our current users at no cost. We plan to offer the COVID-19…
Mint Medical provides a reading template for the standardized assessment and documentation of COVID-19 disease (coronavirus) based on CT imaging
Heidelberg, GER – Mint Medical GmbH, a global MedTech company specialized in software solutions for data-driven radiology, today announced that it…